The highest leukaemia-free survival after allogeneic bone marrow Transplantation is seen in patients with grade I acute graft-versus-host disease

Leukemia and Lymphoma

Volumn 24, Issue 1-2, 1996, Pages 71-79

  Ringden O ^a,f   Hermans, J ^b   Labopin, M ^c   Apperley, J ^d   Gorin, N C ^c   Gratwohl, A ^e  

^a Huddings Hospital   (Sweden)

^b LEIDEN UNIVERSITY   (Netherlands)

^c HÔPITAL SAINT ANTOINE   (France)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute leukemia; Allogenic bone marrow transplantation; Graft versus host disease

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ACUTE LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; BONE MARROW TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, CHRONIC; MALE; MULTIVARIATE ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0030454494     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609045715     Document Type: Article

References (28)

1. Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, F. L., Neiman, P. E., Lerner, K. G., Glucksberg, H. and Buckner, C. D. (1975). Bone-marrow transplantation I and II, N. Engl. J. Med., 292, 832-843, 895-902.
2. Giralt, S. A. and Champlin, R. E. (1994). Leukemia relapse after allogeneic bone marrow transplantation: A review, Blood, 84, 3603-3512.
3. Weiden, P. L., Sullivan, K. M., Flournoy, N , Storb, R , Thomas, E. D. and the Seattle Marrow Transplant Team. (1981). Antileukaemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation, N. Engl. J. Med., 304, 1529-1533.
4. Sullivan, K. M., Weiden, P. L., Storb, R., Witherspoon, R. P., Fefer, A., Fisher, L., Buckner, C. D., Anasetti, C., Appelbaum, F. R., Badger, C., Beatty, P., Bensinger, W., Berenson, R., Bigelow, C., Cheever, M. A., Clift, R., Deeg, H. J., Doney, K., Greenberg, P., Hansen, J. A., Hill, R., Loughran, T., Martin, P., Neiman, P., Petersen, F. B., Sanders, J., Singer, J., Stewart, P. and Thomas, E. D. (1989). Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia, Blood, 73, 1720-1728.
5. Horowitz, M. M., Gale, R P., Sondel, P M., Goldman, J. M., Kersey, J., Kolb, H -J., Rimm, A. A., Ringdén, O., Rozman, C., Speck, B., Truitt R. L., Zwaan, F. E. and Bortin, M. M. (1989). Graft-versus-leukemia reactions following bone marrow transplantation in humans, Blood, 175, 555-562.
6. Gratwohl, A., Hermans, J., Apperley, K., Arcese, W., Bacigalupo, A., Bandini, G., diBartolomeo, P., Boogaerts, M., Bosi, A., Carreras, E., Devergie, A., Ferrant, A., Fibbe, W. E , Frassoni, F., Gahrton, G., Goldman, J., Iriondo, A., Jacobsen, N., Kolb, H. J., Link, H., Michalet, M., Prentice, H. G., Reiffers, J., v Rhee, F., Ruutu, T., Schwaighofer, H., Vernant, J. P., deWitte, T., Niederwieser, D., for the Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. (1995). Acute graft-versus-host disease: Grade and outcome in patients with chronic myelogenous leukemia, Blood, 86, 813-818.
7. Fefer, A., Sullivan, K. M., Weiden, P., Buckner, C. D., Schoch, G., Storb, R. and Thomas, E. D. (1987) Graft-versus-leukemia effect in man: The relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. In Cellular Immunotherapy of Cancer, edited by Truitt R. L , Gale R. P. and Bortin M. M. New York: AR Liss: pp. 401-408.
8. Ringdén, O., Zwaan, F. E., Hermans, J. and Gratwohl, A. for the Leukemia Working Party of the European Group for Bone Marrow Transplantation. (1987). European experience of bone marrow transplantation for leukemia, Transplant. Proc., 19, 2600-2604.
9. Gale, R. P., Horowitz, M. M., Ash, R. C., Champlin, R. E., Goldman, J. M., Rimm, A. A., Ringdén, O., Veum, J. A. and Bortin, M. M. (1994). Identical twin bone marrow transplants for leukemia, Ann Int. Med., 120, 646-652.
10. Goldman, J. M., Gale, R. P., Horowitz, M. M., Biggs, J. C., Champlin, R. E., Gluckman, E., Huffman, R. G., Jacobsen, S. J., Marmont, A. M., McGlave, P. B., Messner, H. A., Rimm, A. A., Rozman, C., Speck, B., Tura, S., Weiner, R. S. and Bortin, M. M. (1988). Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T-cell depletion, Ann. Int. Med., 108, 806-814.
11. Marmont, A. M., Horowitz, M. M., Gale, R. P., Ash, R. C., van Bekkum, D. W., Champlin, R. E., Dicke, K. A., Goldman, J. M., Good, R. A., Herzig, R. H., Hong, R., Masaoka, T., O'Reilly, R. J , Prentice, H. G., Rimm, A. A., Ringdén, O., Speck, B., Weiner, R. S. and Bortin, M. M. (1990). T-cell depletion of HLA-identical transplants in leukemia, Blood, 78, 2120-2130.
12. Aschan, J., Ringdén, O., Sundberg, B., Klaesson, S., Ljungman, P. and Lönnqvist, B. (1993). Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease, Eur. J. Hematol., 50, 269-274.
13. Ringdén, O., Labopin, M., Gluckman, E., Reiffers, J., Vernant, J. P., Jouet, J. P., Harousseau, J. L. and Gorin, N. C. For the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Graft versus leukemia effect in allogeneic marrow transplant recipients with acute leukemia treated with cyclosporin combined with methotrexate. Manuscript submitted for publication
14. Ringdén, O. and Nilsson, B. (1985). Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy, Transplantation, 40, 39-44.
15. Storb, R., Deeg, H. J., Thomas, E. D., Appelbaum, F. R., Buckner, C. D., Cheeve, M. A., Clift, R. A., Doney, K. C., Flornoy, N., Kennedy, M. S., Loughran, T. P., McGuffin, R. W., Gale G. E., Sanders, J. E., Singer, J. W., Stewart, P S., Sullivan, K. M. and Witherspoon, R. P. (1985). Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease, Blood, 66, 698-702.
16. Storb, R., Deeg, H. J., Whitehead, J , Appelbaum, F , Beatty, P., Bensinger, W., Buckner, C. D., Clift, R., Doney, K , Farewell, V., Hansen, J., Hill, R., Lum, L., Martin, P., McGuffin, R., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., Yee, G. and Thomas, E. D. (1986) Methotrexate and cyclosporine compared with cyciosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia, N. Engl. J. Med., 314, 729-735.
17. Storb, R., Deeg, H. J., Pepe, M., Appelbaum, R. Anasetti, C., Beatty, P., Bensinger, W., Berenson, R., Buckner, C. D., Clift, R, Doney, K., Longton, G., Hansen, J. Hill, R., Loughran, Jr. T., Martin, P., Singer, J., Sanders, J., Stewart, P. and Sullivan, K. (1989). Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for ieukemia: Long-term follow-up of a controlled trial, Blood, 73, 1729-1734.
18. Ringdén, O., Horowitz, M. M., Sondel, P., Gale, R. P., Biggs, J. G., Champlin, R. E., Deeg, H. J., Dicke, K., Masaoka, T., Powles, R. L., Rimm, A A., Rozman, C., Sobocinski, K. A., Speck, B., Zwaan, F. E. and Bortin, M. M. (1993). Methotrexate, cyclosporine or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood, 81, 1094-1101.
19. Kaplan, E. I. and Meier, P. (1958). Non-parametric estimation for incomplete observations, J. Am. Stat. Assoc., 53, 457-481.
20. Cox, D. R. Regression models and life tables. (1972). J. R. Stat. Soc. Ser. B., 34, 187-220.
21. Ringdén, O., Sundberg, B., Lönnqvist, B., Tollemar, J., Gahrton, G. and Nilsson, B. (1988). Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse, Bone Marrow Transplant, 3, 281-290.
22. Bacigalupo, A., Van Lint, M. T., Occhini, D. et al (1991). Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia, Blood, 77, 1423-1428.
23. Aschan, J., Ringdén, O., Sundberg, B., Gahrton, G., Ljungman, P. and Winiarski, J. (1991). Methotrexate combined with cyclosporine A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy, Bone Marrow Transplant, 7, 113-119.
24. Weaver, C. H., Hansen, J. A., Martin, P. O , Sanders, J., Sullivan, K. M., Thomas, E. D., Singer, J., Witherspoon, R. and Buckner, C. D. (1994). Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia, Bone Marrow Transplant, 14, 885-893.
25. Prentice, H. G., Blacklock, H. A., Janossy, G., Gilmore, M. J. M. L., Prince-Jones L., Tidman, N., Trejdosiewicz, L. K., Skeggs, D. B. L., Panjwani, O., Ball, S., Graphakos, S., Patterson, J., Ivory, K., and Hoffbrand, A. V. Depletion of T lymphocytes in donor marrow prevents significant graft versus host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984;i:472-475.
26. Ringdén, O., Remberger, M., Aschan, J., Ljungman, P., Lönnqvist, B. and Markling, L. (1994). Long-term follow-up of a randomized trial comparing T-cell-depletion with a combination of methotrexate and cyclosporin in adult leukemic marrow transplant recipients, Transplantation, 58, 887-891.
27. Naparstek, E., Or, R., Nagler, A., Cividalli, G., Engelhard, D., Aker, M., Gimon, Z., Manny, N., Sachs, T., Tochner, Z., Weiss, L , Samuel, S., Brautbar, C., Hale, G., Waldmann, H., Steinberg, S. M. and Slavin, S. (1995). T-cell-depleted allogeneic bone marrow transplantation of acute leukemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse, Br. J. Haematol., 89, 506-515.
28. Verdonck, L. F., Dekker, A. W., de Gast, G. C., van Kempen, L., Lokhorst and Nieuwenhuis, H. K. (1994). Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft, Blood, 83, 3090-3096.